Royal Bank of Canada Sells 6,075 Shares of The Cooper Companies, Inc. $COO

Key Points

• Royal Bank of Canada reduced its stake in The Cooper Companies, Inc. by 1.3%, now holding approximately 469,348 shares valued at about $39.59 million.
• Multiple institutional investors increased their holdings in The Cooper Companies during the first quarter, with Mirae Asset Global Investments Co. Ltd. leading with a 15.1% increase.
• Insider purchases include Brian G. Andrews and Gerard H. Warner III, who increased their ownership by 7.38% and 8.60%, respectively, indicating positive insider sentiment.

Royal Bank of Canada reduced its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 469,348 shares of the medical device company's stock after selling 6,075 shares during the period. Royal Bank of Canada owned approximately 0.23% of Cooper Companies worth $39,590,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of COO. Mirae Asset Global Investments Co. Ltd. increased its position in Cooper Companies by 15.1% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock worth $2,194,000 after buying an additional 3,440 shares during the period. DAVENPORT & Co LLC boosted its holdings in shares of Cooper Companies by 13.4% in the first quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock worth $366,000 after buying an additional 513 shares during the period. Cerity Partners LLC boosted its holdings in shares of Cooper Companies by 6.6% in the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company's stock worth $1,443,000 after buying an additional 1,054 shares during the period. State of Alaska Department of Revenue boosted its position in Cooper Companies by 3.0% during the 1st quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock worth $1,972,000 after acquiring an additional 680 shares during the period. Finally, Cetera Investment Advisers boosted its position in Cooper Companies by 1.3% during the 4th quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock worth $2,211,000 after acquiring an additional 312 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.7%

COO traded down $0.46 on Wednesday, hitting $67.79. 1,445,870 shares of the company were exchanged, compared to its average volume of 2,297,728. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $112.38. The company has a market cap of $13.48 billion, a PE ratio of 33.41, a PEG ratio of 1.74 and a beta of 0.97. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The stock's fifty day moving average is $71.85 and its 200-day moving average is $76.37.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the business earned $0.96 earnings per share. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on COO. Needham & Company LLC reiterated a "buy" rating and set a $94.00 price target on shares of Cooper Companies in a report on Thursday, August 28th. BNP Paribas Exane raised Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective on the stock in a research note on Tuesday, July 22nd. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $76.00 to $66.00 and set a "neutral" rating on the stock in a research report on Thursday, August 28th. Wall Street Zen cut Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Finally, Wells Fargo & Company decreased their target price on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating on the stock in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and an average price target of $86.64.

Insider Transactions at Cooper Companies

In other Cooper Companies news, COO Daniel G. Mcbride purchased 3,000 shares of the company's stock in a transaction dated Tuesday, September 2nd. The stock was purchased at an average price of $65.04 per share, with a total value of $195,120.00. Following the completion of the purchase, the chief operating officer owned 63,120 shares of the company's stock, valued at approximately $4,105,324.80. The trade was a 4.99% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Albert G. White III purchased 10,000 shares of the firm's stock in a transaction on Friday, September 5th. The shares were acquired at an average price of $68.39 per share, with a total value of $683,900.00. Following the completion of the acquisition, the chief executive officer owned 226,151 shares in the company, valued at approximately $15,466,466.89. This trade represents a 4.63% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 15,975 shares of company stock valued at $1,079,566 over the last three months. Company insiders own 1.98% of the company's stock.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.